Plenty of cash. Expecting $4mill to be received in current quarter once tax return is lodged and r and d comes in.
Of the $5.35 mill they are spending in December $4.75 mill is r and d on phase 2. Beauty of that is the company will get about 40% of that back next time around.
Should see the company with around $13 mill in bank @ 31st December with a large spend on phase 2 trials.
Prudent cash management. Absolutely brilliant imo.
The product range is insane. Really looking forward to this building into the new year now.
Ann: Appendix 4C - Quarterly, page-6
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
